drugset / Trial / NCT00414778

Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects

NCT00414778 ↗

Phase 1 Completed 12 enrolled Novartis
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate safety and pharmacokinetics of a single and multiple dose of LHT344 in 12 Chinese healthy subjects. This study is not recruiting subjects in the United States.

Timeline

Start
2006-10
Primary completion
2006-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject LHT344 Unknown — Oral

Indications

No indication recorded.